METAGENOMI THERAPEUTICS INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$0.78
-6.01%
Alpha Vantage · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
-29.4%
3 months
-35.5%
6 months
-43.9%
1 year
-68.0%
Year to date
-51.9%
52-week range
$0.77 – $2.54
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$29.5M
P/E
-0.3
P/B
0.3
P/S
2.2
Revenue
$13.56M
Net income
-$93.46M
Diluted EPS
-2.49
Gross margin
100.00%
Net margin
-689.20%
Return on equity
-63.60%
Total debt
$37.72M
Cash
$43.42M
Free cash flow
-$85.8M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | -$257K | -$27.48M | 100.00% | 10693.40% | -$19.64M |
| Mar 31, 2026 | $1.25M | -$23.06M | 100.00% | -1847.70% | -$21.2M |
| Dec 31, 2025 | $3.91M | -$22.53M | 100.00% | -576.00% | -$23.63M |
| Sep 30, 2025 | $8.66M | -$20.39M | 100.00% | -235.50% | -$21.33M |
| Jun 30, 2025 | $8.51M | -$19.91M | 100.00% | -233.90% | -$21.34M |
| Mar 31, 2025 | $4.13M | -$25.04M | 100.00% | -606.70% | -$23.13M |
| Dec 31, 2024 | $9.61M | -$23.4M | 100.00% | -243.40% | -$26.61M |
| Sep 30, 2024 | $11.51M | -$18.77M | 100.00% | -163.00% | -$27.84M |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent MGX news
All market newsNo ticker-linked stories are in the current archive.